Other cohorts have recognized an increasing trend toward nonluminal A subtypes with increasing tumor size and lymph node metastases; this differs from our results but, likewise, shows that intrinsic subtypes are a stronger prognostic indicator for outcomes than IHC subtypes ( 34 , 37 ).
← all excerpts
Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study.
1
—
—